Theoretical and practical considerations for the measurement of P-glycoprotein function in acute myeloid leukemia

被引:0
作者
HJ Broxterman
J Lankelma
HM Pinedo
CA Eekman
DCR Währer
GJ Ossenkoppele
GJ Schuurhuis
机构
[1] Academisch Ziekenhuis Vrije Universiteit,Department of Medical Oncology
[2] Academisch Ziekenhuis Vrije Universiteit,Department of Hematology
来源
Leukemia | 1997年 / 11卷
关键词
P-glycoprotein; multidrug resistance; leukemia; PSC833; rhodamine 123;
D O I
暂无
中图分类号
学科分类号
摘要
This paper summarizes experimental data and theoretical considerations, that are important for the measurement of P-glycoprotein (Pgp) function in acute myeloid leukemia (AML). The data are presented in subdivisions based on the techniques used, which will facilitate finding specific information. Based on our extensive experience with Pgp analysis, which includes radioactive assays, flow cytometry and fluorescence microscopy, we recommend a flow cytometry-based assay, that measures the effect of 2 μ M PSC 833 on rhodamine 123 (R123) accumulation as the most practical and sensitive functional Pgp test. In combination with the flow cytometric measurement of Pgp using an antibody against an extracellular epitope (eg MRK16), this offers a sensitive and reproducible method for Pgp detection in AML, which is also rapid and practical. Furthermore, an R123 accumulation assay is specific for Pgp, because R123 is transported much less efficiently by the multidrug resistance protein (MRP) than by Pgp. Another probe of similar sensitivity and specificity is 3,3′-diethyloxacarbocyanine iodide. Alternatively, especially for the analysis of small numbers of cells (for example sorted subpopulations of leukemic cells), convenient and sensitive procedures are being developed by using DNA-binding Pgp substrates which remain fixed in the nuclei of the cells upon formaldehyde exposure for quantitative fluorescence laser scanning microscopy with image analysis. Less experimental data have been published to establish the optimal conditions for dual parameter flow cytometry (Pgp function, in eg Pgp+ or CD34+ cells). However, laboratories with flow cytometry experience will be able to implement this useful option to analyze subpopulations of cells.
引用
收藏
页码:1110 / 1118
页数:8
相关论文
共 50 条
  • [41] A Review of P-Glycoprotein Function and Regulation in Fish
    Johnston, Christina U.
    Kennedy, Christopher J.
    FISHES, 2024, 9 (02)
  • [42] 10-Phenyltriazoyl Artemisinin is a Novel P-glycoprotein Inhibitor that Suppresses the Overexpression and Function of P-glycoprotein
    Lee, Dong-Hwan
    Hasanuzzaman, Md
    Kwon, Daeho
    Choi, Hye-Young
    Kim, So Myoung
    Kim, Dong Jin
    Kang, Dong Ju
    Hwang, Tae-Ho
    Kim, Hyung-Hoi
    Shin, Ho Jung
    Shin, Jae-Gook
    Oh, Sangtae
    Lee, Seokjoon
    Kim, So Won
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (46) : 5590 - 5597
  • [43] Simultaneous measurement of cellular P-glycoprotein content and function by multiparametric flow-cytometry
    Müller, MR
    Lennartz, K
    Baack, B
    Heim, MME
    Seeber, S
    Scheulen, ME
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2000, 38 (04) : 180 - 186
  • [44] Towards Comprehension of the ABCB1/P-Glycoprotein Role in Chronic Myeloid Leukemia
    Maia, Raquel C.
    Vasconcelos, Flavia C.
    Souza, Paloma S.
    Rumjanek, Vivian M.
    MOLECULES, 2018, 23 (01):
  • [45] Role of P-glycoprotein in evolution of populations of chronic myeloid leukemia cells treated with imatinib
    T. P. Stromskaya
    E. Yu. Rybalkina
    S. S. Kruglov
    T. N. Zabotina
    E. B. Mechetner
    A. G. Turkina
    A. A. Stavrovskaya
    Biochemistry (Moscow), 2008, 73 : 29 - 37
  • [46] P-glycoprotein in primary acute myeloid leukemia and treatment outcome of idarubicin/cytosine arabinoside-based induction therapy
    Broxterman, HJ
    Sonneveld, P
    van Putten, WJL
    Lankelma, J
    Eekman, CA
    Ossenkoppele, GJ
    Pinedo, HM
    Löwenberg, B
    Schuurhuis, GJ
    LEUKEMIA, 2000, 14 (06) : 1018 - 1024
  • [47] P-glycoprotein in primary acute myeloid leukemia and treatment outcome of idarubicin/cytosine arabinoside-based induction therapy
    HJ Broxterman
    P Sonneveld
    WJL van Putten
    J Lankelma
    CA Eekman
    GJ Ossenkoppele
    HM Pinedo
    B Löwenberg
    GJ Schuurhuis
    Leukemia, 2000, 14 : 1018 - 1024
  • [48] Role of P-glycoprotein in evolution of populations of chronic myeloid leukemia cells treated with imatinib
    Stromskaya, T. P.
    Rybalkina, E. Yu.
    Kruglov, S. S.
    Zabotina, T. N.
    Mechetner, E. B.
    Turkina, A. G.
    Stavrovskaya, A. A.
    BIOCHEMISTRY-MOSCOW, 2008, 73 (01) : 29 - 37
  • [49] Evidence of a role for functional heterogeneity in multidrug resistance transporters in clinical trials of P-glycoprotein modulation in acute myeloid leukemia
    Marcelletti, John F.
    Sikic, Branimir I.
    Cripe, Larry D.
    Paietta, Elisabeth
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2019, 96 (01) : 57 - 66
  • [50] Immunocytochemical detection of the multidrug resistance-associated protein and P-glycoprotein in acute myeloid leukemia: Impact of antibodies, sample source and disease status
    Filipits, M
    Suchomel, RW
    Lechner, K
    Pirker, R
    LEUKEMIA, 1997, 11 (07) : 1073 - 1077